A carregar...

Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs

Oncolytic virotherapy is an emerging strategy that uses replication-competent viruses to kill tumor cells. We have reported the oncolytic effects of TG6002, a recombinant oncolytic vaccinia virus, in preclinical human xenograft models and canine tumor explants. To assess the safety, biodistribution...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Béguin, Jérémy, Gantzer, Murielle, Farine, Isabelle, Foloppe, Johann, Klonjkowski, Bernard, Maurey, Christelle, Quéméneur, Éric, Erbs, Philippe
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7838210/
https://ncbi.nlm.nih.gov/pubmed/33500518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-81831-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!